These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 12902520)

  • 1. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
    Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
    J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
    Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
    Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
    Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
    Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.
    Dunbar PR; Smith CL; Chao D; Salio M; Shepherd D; Mirza F; Lipp M; Lanzavecchia A; Sallusto F; Evans A; Russell-Jones R; Harris AL; Cerundolo V
    J Immunol; 2000 Dec; 165(11):6644-52. PubMed ID: 11086110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
    von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
    Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
    Labarriere N; Pandolfino MC; Raingeard D; Le Guiner S; Diez E; Le Dréan E; Dreno B; Jotereau F
    Int J Cancer; 1998 Oct; 78(2):209-15. PubMed ID: 9754654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
    Speiser DE; Colonna M; Ayyoub M; Cella M; Pittet MJ; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini JC; Romero P
    J Immunol; 2001 Dec; 167(11):6165-70. PubMed ID: 11714776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity.
    Mallard E; Vernel-Pauillac F; Velu T; Lehmann F; Abastado JP; Salcedo M; Bercovici N
    J Immunol; 2004 Mar; 172(6):3963-70. PubMed ID: 15004205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
    Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
    Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
    Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
    Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
    Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers.
    Ravkov EV; Myrick CM; Altman JD
    J Immunol; 2003 Mar; 170(5):2461-8. PubMed ID: 12594271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H; Takiguchi M
    J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
    Valmori D; Dutoit V; Liénard D; Lejeune F; Speiser D; Rimoldi D; Cerundolo V; Dietrich PY; Cerottini JC; Romero P
    J Immunol; 2000 Jul; 165(1):533-8. PubMed ID: 10861093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics.
    Faint JM; Annels NE; Curnow SJ; Shields P; Pilling D; Hislop AD; Wu L; Akbar AN; Buckley CD; Moss PA; Adams DH; Rickinson AB; Salmon M
    J Immunol; 2001 Jul; 167(1):212-20. PubMed ID: 11418651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.
    Lee JJ; Yeh CY; Jung CJ; Chen CW; Du MK; Yu HM; Yang CJ; Lin HY; Sun A; Ko JY; Cheng SJ; Chang YL; Chia JS
    PLoS One; 2014; 9(1):e85521. PubMed ID: 24465587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.
    Jäger E; Höhn H; Necker A; Förster R; Karbach J; Freitag K; Neukirch C; Castelli C; Salter RD; Knuth A; Maeurer MJ
    Int J Cancer; 2002 Mar; 98(3):376-88. PubMed ID: 11920589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
    Romero P; Zippelius A; Kurth I; Pittet MJ; Touvrey C; Iancu EM; Corthesy P; Devevre E; Speiser DE; Rufer N
    J Immunol; 2007 Apr; 178(7):4112-9. PubMed ID: 17371966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
    Tomiyama H; Matsuda T; Takiguchi M
    J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.